Overview

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
1. To investigate the effect of kidney function on the elimination of a single dose of PD 0332334 from the body. 2. To investigate the safety and tolerability of a single dose of PD 0332334 in patients with impaired kidney function.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer